However, current knowledge regarding the potential function of CXCL14 in immunotherapy is limited only to the recruitment of NK and/or T cells to the tumour microenvironment, whereas the mechanism by which CXCL14 suppresses tumour development remains unclear. This evidence concerns the gene CXCL14 and neoplasm.